Federal award
TEVA PHARMACEUTICALS USA, INC.
W81XWH05C0157
Contract
Obligated and Ceiling
- Obligated (net)
- $2,269,469.58
- Ceiling (potential value, not spending)
- —
- Current value
- —
- Gross positive obligations
- $3,057,130.42
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- TEVA PHARMACEUTICALS USA, INC. · NEN9A34LRHJ5
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- TEVA PHARMACEUTICAL INDUSTRIES LTD. · DYLJM9RQJ167
- Awarding agency
- Department of War · sub-agency 2100 · office W81XWH
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- AN91 · R&D- MEDICAL: OTHER (BASIC RESEARCH)
- Industry (NAICS)
- 541710 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES
- PIID
- W81XWH05C0157
- Award type code
- D
- Actions
- 17 · May 13, 2008 to Feb 17, 2017
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History17
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 17, 2017 | FY2017 | P00025 | C | −$11,230.00 | — |
| May 11, 2016 | FY2016 | P00024 | M | $0.00 | — |
| Apr 29, 2016 | FY2016 | P00023 | C | −$5,180.00 | — |
| Sep 11, 2015 | FY2015 | P00022 | C | −$458,120.42 | — |
| Feb 4, 2013 | FY2013 | P00021 | M | $0.00 | — |
| Sep 20, 2012 | FY2012 | P00020 | C | $313,130.42 | — |
| Aug 14, 2012 | FY2012 | P00019 | M | $0.00 | — |
| Aug 18, 2011 | FY2011 | P00018 | C | −$313,130.42 | — |
| Aug 11, 2011 | FY2011 | P00017 | C | $266,509.00 | — |
| Jun 29, 2011 | FY2011 | P00015 | B | $439,791.00 | — |
| Aug 3, 2010 | FY2010 | P00014 | M | $0.00 | — |
| May 7, 2010 | FY2010 | P00013 | C | $0.00 | — |
| Apr 29, 2010 | FY2010 | P00012 | C | $934,500.00 | — |
| Aug 27, 2009 | FY2009 | P00011 | B | $664,500.00 | — |
| Apr 9, 2009 | FY2009 | P00010 | B | $45,000.00 | — |
| Feb 2, 2009 | FY2009 | P00009 | B | $393,700.00 | — |
| May 13, 2008 | FY2008 | P00008 | M | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.